ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How Lymphatic Drainage Controls Synovial Inflammation

Michael Cammarata, MD  |  November 2, 2025

Although first described in mouse models, this phenomenon has since been demonstrated in humans. In acute onset rheumatoid arthritis, magnetic resonance imaging demonstrated expanding popliteal lymph nodes while patients with end-stage, chronic RA have small, collapsed popliteal lymph nodes.5 Similarly, Bell and colleagues demonstrated that healthy hands are able to efficiently drain lymphatic fluid, while patients with active, symptomatic rheumatoid arthritis are have impaired ability to drain indocyanine green, with complete loss of drainage from some lymphatic vessels.6

Lymphatic Models in Inflammatory Arthritis

The lymphatic system is a relatively simple network because there are only two component cells: lymphatic endothelial cells and lymphatic muscle cells. Dr. Schwarz highlighted the work of Scallan et al., who developed an ex vivo system to study the contractile ability of the popliteal lymphatic vessel. Once the lymphatic vessel was removed ex vivo and cannulated, it was flushed with fluid, and they observed coordinated, tonic lymphatic vessel contractions.7

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Schwarz contrasted this coordinated contractile ability with that seen in TNF alpha transgenic mice with inflammatory arthritis—meaning the mice have been genetically engineered to express the TNF-alpha gene leading to inflammation arthritis. In these mice, lymphatic contractions in expanding lymphatics demonstrate an engorged vessel with reduced tonicity and rhythm, while the collapsed lymphatic vessel is essentially non-functional.8 TNF transgenic mice were found to have lymphatic vessels devoid of the normal extracellular matrix, thus reducing contractible ability. Dr. Schwarz then posed the question, what comprises this extracellular matrix and what is its role?

Immersed in the extracellular matrix and buried in the vessel endothelium, popliteal lymphatic vessels are surrounded by mast cells. When these cells are removed or stabilized with cromolyn sodium in a TNF transgenic mouse model, this leads to loss of lymphatic drainage and exacerbation of inflammatory arthritis. This led to the proposal that endothelial mast cells help promote extracellular matrix production and release mediators, such as histamine, to stimulate vessel contractility.9

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Tale of the Telocyte

In an effort to generate a conditional-inducible genetic model in mice for gain and loss of function in lymphatic muscle cells, Dr. Schwarz and his laboratory ultimately discovered the presence of telocytes, which are fibroblastic cells present in all tissues. Telocytes are also known as “nurse cells” given their ability to transmit extracellular matrix, organelles, DNA and RNA into other cells and “nurse” them back to health. Structurally, telocytes have very long dendritic pods calls telopods to communicate with other cell types.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAlymphaticsmast cellsynovitistelocytes

Related Articles
    Figures 1 & 2: Transverse and longitudinal ultrasound views, respectively, of the left posterior knee, revealing a cystic mass with heterogeneous internal echotexture and no stalk.

    Ultrasound Aids Diagnosis of Man with Knee Pain & Swelling

    November 17, 2019

    A 56-year-old automobile mechanic was referred to our rheumatology service by his orthopedist to evaluate left posterior knee pain and swelling that had been present for three months. The patient had undergone bilateral total knee arthroplasties (TKAs) for sports-related osteo­arthritis three years before. In addition to the knee pain, the patient described several years of…

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

    Vasculitis

    June 1, 2009

    A New perspective on when and how it begins

    Doest Rheumatoid Arthritis Take a Toll?

    November 15, 2013

    Exploring the Toll background

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences